Literature DB >> 25668676

Reply to Claude Lambert.

Salvatore Chirumbolo1.   

Abstract

Mesh：

Year:  2014        PMID： 25668676      PMCID： PMC4514094          DOI： 10.4161/21645515.2014.980208

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN： 2164-5515            Impact factor:   3.452


× No keyword cloud information.
  6 in total

1.  The use of IL-3 in basophil activation tests is the real pitfall.

Authors:  Salvatore Chirumbolo
Journal:  Cytometry B Clin Cytom       Date:  2010-09-15       Impact factor: 3.058

2.  CCR3 as a single selection marker compared to CD123/HLADR to isolate basophils in flow cytometry: some comments.

Authors:  S Chirumbolo; Riccardo Ortolani; Antonio Vella
Journal:  Cytometry A       Date:  2010-12-30       Impact factor: 4.355

3.  Basophil activation test in allergy: time for an update?

Authors:  Salvatore Chirumbolo
Journal:  Int Arch Allergy Immunol       Date:  2012-01-20       Impact factor: 2.749

Review 4.  Immunotherapy in allergy and cellular tests: state of art.

Authors:  Salvatore Chirumbolo
Journal:  Hum Vaccin Immunother       Date:  2014-05-02       Impact factor: 3.452

5.  Major pitfalls in BAT performance may be caused by gating protocols and CD63% cut off evaluation.

Authors:  Salvatore Chirumbolo
Journal:  Cytometry A       Date:  2014-05       Impact factor: 4.355

6.  Use of basophil activation test in the investigation of adverse effects to vaccines.

Authors:  Salvatore Chirumbolo
Journal:  Hum Vaccin       Date:  2011-08-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.